West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
209.13
0.00 (0.00%)
Apr 17, 2025, 4:00 PM EDT - Market closed
WST Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for WST stock have an average target of 349, with a low estimate of 275 and a high estimate of 400. The average target predicts an increase of 66.88% from the current stock price of 209.13.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 18, 2025.
Analyst Ratings
The average analyst rating for WST stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 4 | 3 | 3 | 3 |
| Buy | 2 | 1 | 1 | 1 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $275 | Buy | Initiates | $275 | +31.50% | Mar 18, 2025 |
| Keybanc | Keybanc | Buy Maintains $470 → $325 | Buy | Maintains | $470 → $325 | +55.41% | Feb 14, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $400 | Strong Buy | Initiates | $400 | +91.27% | Jan 8, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $350 → $355 | Strong Buy | Maintains | $350 → $355 | +69.75% | Dec 13, 2024 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Dec 13, 2024 |
Financial Forecast
Revenue This Year
2.92B
from 2.89B
Increased by 0.96%
Revenue Next Year
3.12B
from 2.92B
Increased by 6.64%
EPS This Year
6.18
from 6.69
Decreased by -7.56%
EPS Next Year
7.15
from 6.18
Increased by 15.61%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.0B | 3.3B | 3.5B | ||
| Avg | 2.9B | 3.1B | 3.3B | ||
| Low | 2.8B | 3.0B | 3.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.3% | 13.9% | 13.9% | ||
| Avg | 1.0% | 6.6% | 6.9% | ||
| Low | -2.5% | 1.5% | -0.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.74 | 8.03 | 9.80 | ||
| Avg | 6.18 | 7.15 | 8.13 | ||
| Low | 5.88 | 6.50 | 7.10 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.8% | 29.9% | 37.0% | ||
| Avg | -7.6% | 15.6% | 13.8% | ||
| Low | -12.1% | 5.1% | -0.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.